Trial Profile
Single Oral Dose Study of C13-URA Breath Test in Cancer Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Uracil (Primary)
- Indications Cancer
- Focus Adverse reactions; Diagnostic use
- Sponsors Otsuka Pharmaceutical
- 14 Jun 2016 New trial record